Clinical Trial Update: Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

View source ↗

Summary

Post-marketing surveillance study evaluating long-term safety and real-world use of bixalomer (Kiklin) capsules for hyperphosphatemia in patients on peritoneal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Kiklin (bixalomer)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Renal Failure | Status: COMPLETED